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Abstract
Background: The purpose of this study was to further characterize the immune response to
Mycobacterium tuberculosis (Mtb) antigens, in order to provide new insight into host-pathogen
interactions in tuberculosis (TB), and to offer tools for a more accurate diagnosis of the different
stages of TB.
Methods: T-cell responses to Bacillus Calmette-Guérin (BCG), purified protein derivative (PPD),
early secretory antigenic target-6 (ESAT-6) protein and culture filtrate protein-10 kDa (CFP-10)
were measured in terms of interferon (IFN)-γ and interleukin (IL)-2 release, using a novel flow
cytometric cell-secreting cytokine detection technique. The study was conducted on peripheral
blood mononuclear cells (PBMC) obtained from active TB patients, latently TB infected individuals,
and healthy donors. IL-10 and IL-17 were also measured to test their possible role as indicators of
disease activity.
Results: We confirmed that the enumeration of IFN-γ releasing cells upon Mtb-specific stimulation
is sufficient to identify TB patients and that CD8+ T cells concur to IFN-γ secretion. IL-2 secreting
cells were more frequently observed in latent TB infected individuals compared to active TB
patients, suggesting that measurement of cells secreting this cytokine could be a marker of disease
stage. No discriminating role was associated to IL-10 and IL-17 release in TB patients.
Conclusion:  Our data indicate that the flow cytometric cytokine-secreting cell detection
technique may be envisaged as an additional tool for TB diagnosis allowing the analysis of the
immune response to M. tuberculosis-related antigens in the different stages of TB.
Background
Tuberculosis (TB) is one of the most prevalent bacterial
infections of humans worldwide [1], but the large major-
ity of M. tuberculosis infected individuals are asympto-
matic. In fact, healthy individuals who get infected by M.
tuberculosis for the first time usually develop a mild dis-
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ease: primary TB. These individuals clinically heal, but are
unable to clear the bacterium that remains dormant
within granulomas or cellular reservoirs [2-4]. This latent
TB infection may have a lifelong persistence, without clin-
ical relevance [5]. In some subjects, due to concomitant
infections, malnutrition or other factors, latent M. tubercu-
losis may reactivate causing a post-primary TB that usually
develops chronically, unless treated with antibiotics [6,7].
One of the main problems in the fight against TB is the
correct diagnosis of its different stages. Tuberculin skin
test (TST) is the most used screening method for the diag-
nosis of M. tuberculosis infection, even though a prior vac-
cination with Bacillus Calmette Guérin (BCG) can lead to
false positive results using this test. Other widely recog-
nized limits of TST are the false negative tests due to
anergy or immune deficiency and its inability to distin-
guish latently infected individuals from patients with
active TB. Moreover, the site of the skin test must be exam-
ined by a health professional within 48 – 72 hours to
determine the result of the test [8,9]. Newer assays based
on the release of interferon (IFN)-γ upon specific antigen
stimulation (IGRAs) have recently become available [10-
12], but their enhanced sensitivity and specificity com-
pared to TST [8,13] have not been demonstrated yet.
These tests take advantage by the use of early secretory
antigenic target-6 (ESAT-6) and culture filtrate protein-10
kDa (CFP-10), proteins that are encoded within the
region of difference 1 (RD1) of M. tuberculosis but not
BCG genome, and thus are not synthesized by BCG sub-
strains or most environmental mycobacteria, with few
exceptions [14-16]. In addition, some of these tests are
commercially available and approved for TB infection
diagnosis. However, IGRAs can discriminate vaccinated
from M. tuberculosis-infected individuals, but not patients
affected by active TB disease from individuals with latent
TB infection. Lastly, the instrumentation required to per-
form some of IGRAs is not available in all laboratories
[17,18].
A possible contribution to discriminate the different TB
stages could be envisaged in a more accurate definition of
the immunological response to selected M. tuberculosis
antigens. In fact, the immune response should differ
according to the antigen load, i.e. to active disease or
latent infection. Since effector T cells (TEM) have a limited
lifespan, it is possible to hypothesize that in the presence
of active bacterial replication, i.e. active disease, their fre-
quency should be increased in comparison to central
memory T cells (CEM) in peripheral blood mononuclear
cells (PBMC), whereas CEM should be predominant in
latent infections. Beside phenotypic surface markers,
memory cells can be distinguished according to their dif-
ferential cytokine secretion: TEM secrete IFN-γ alone while
CEM interleukin (IL)-2 or IFN-γ and IL-2. Moreover, they
show different kinetics of stimulation: rapid (hours) for
TEM and longer (days) for CEM [19,20]. In this line, it has
been recently shown that M. tuberculosis specific T cell
response in patients with a non-replicating M. tuberculosis
infection is mainly characterized by IL-2-secreting T cells
[21].
In this study we investigate the possible contribution of
active cytokine-secreting memory T cell enumeration as a
diagnostic tool for TB infection and disease using a mod-
ified commercially available method [22,23].
Methods
Study population
Patients admitted to the infectious diseases ward at the
National Institute for Infectious Diseases 'L. Spallanzani',
Rome, Italy, between 2007 and 2008 were evaluated for
enrolment. Individuals underwent TST administered by
the Mantoux procedure using 5 IU of purified protein
derivative (PPD) (Chiron, Siena, Italy) and after 72 h an
induration of at least 10 mm was scored positive. TST and
in vitro T cell assays were performed at the same time
within a week from the admission. Enrolled individuals
were classified as 'active TB' when the diagnosis was con-
firmed by a positive M. tuberculosis culture from sputum
specimens. For those with a diagnosis of extra-pulmonary
TB, a polymerase chain reaction was positive for M. tuber-
culosis  on biopsies or on pleural fluid. None of the
patients resulted positive for human immunodeficiency
virus (HIV) screening. The "healthy subjects" were labora-
tory personnel from Italy with no known exposure to M.
tuberculosis.
Latent TB infection was defined by a positive response to
TST and to the QuantiFERON TB Gold in tube (Cellestis
Ltd, Victoria, Australia) in exposed individuals without
signs of active disease. The study was approved by the Eth-
ical Committee of the Institute and all enrolled individu-
als gave their written informed consent. Demographic and
clinical characteristics of enrolled individuals are reported
in table 1.
Growth of mycobacteria
BCG (ATCC 27291) was grown in Middlebrook 7H10
agar (Difco Laboratories, Detroit, MI) at 37°C under a
humidified 5% CO2 atmosphere for two weeks and col-
ony-forming units were counted as previously described
[24].
Cell isolation and culture
PBMC were purified from heparinized blood obtained on
a density gradient (Lymphoprep, Nicomed Pharma AS,
Oslo, Norway) as previously described [25]. PBMC were
resuspended in RPMI 1640, supplemented with 100 U/ml
kanamycin, 1 mM glutamine, 1 mM sodium pyruvate, 1%
nonessential amino acids, and 5% human AB serum
(complete medium: CM) (all from Euroclone Ltd.,BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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Wetherby Yorkshire, UK), and cultured at 5 × 105 cells/ml
for 18 and 72 hours. Cell cultures were treated with sta-
phylococcal enterotoxin A (SEA, Sigma Chemical Co. St.
Louis, USA) at 0.5 μg/ml, PPD (Statens Serum Institut,
Copenhagen, DK) at 5 μg/ml, a pool of ESAT-6 protein
(Statens Serum Institut) and CFP-10 (Lionex, Braunsch-
weig, Germany) at 5 μg/ml and 2 μg/ml respectively, and
BCG at the multiplicity of infection 1:1 [26]. Negative
controls included un-stimulated PBMC.
Cell-culture supernatants were collected for cytokine
determination by ELISA. 
QuantiFERON TB Gold
QuantiFERON TB Gold in tube assay was performed as
indicated by the manufacturer.
Enumeration of cytokine-secreting-cells by flow 
cytometric analysis
Secretion Assay
Antigen specific T cells were analyzed using IFN-γ, IL-2
and IL-10 Secretion Assays (Miltenyi Biotec, Bergisch
Gladbach, Germany). After 18 and 72 hours of culture,
cells were incubated for 5 minutes on ice with IFN-γ and
IL-2 or IL-10 Catch Reagents (Miltenyi, amounts accord-
ing to manufacturer's instructions). Cells (105 cells/ml)
were then diluted adding warm (37°C) CM, and incu-
bated for 45 minutes under slow continuous rotation at
37°C and 5% CO2. Cells were further incubated for 10
minutes with the Detection Antibodies anti-IFN-γ mAb
(mouse IgG1) FITC-conjugated, anti IL-2 mAb (mouse
IgG1) PE-conjugated, or anti   IL-10 mAb (mouse IgG1)
APC-conjugated (Miltenyi, amounts according to manu-
facturer's instructions). In addition, cells were incubated
with a mAb anti-CD4 (PE-Cy7 conjugated, clone SK3,
mouse IgG1), anti-CD8 (APC-Cy7 conjugated, clone SK1,
mouse IgG1), anti-CD16 (PE-Cy5, clone 3G8, mouse
IgG1). All the mAbs and isotype-matched controls were
purchased from BD PharMingen, San Diego, CA.
Flow cytometry was performed on a FACSCanto flow
cytometer (Becton Dickinson, San Jose, CA) analyzing
50000 viable cells and data were analyzed with the
BDFACS Diva software. The percentages of IFN-γ+, IL-2+,
IFN-γ+/IL-2+  (double positive) or IL-10+  events were
determined with quadrant statistics on CD16- popula-
tion or on CD4+ and CD8+ gated cell population. The
characteristics of the method used do not allow a linear
quantification of cytokine secreting cells when their fre-
quency is higher than 5%. Since our aim was not to
determine the absolute number of cytokine secreting
cells but to analyze the antigen dependence of their syn-
thesis, we assigned the arbitrary value of 6% to all the
frequencies of cytokine secreting cells higher than 5%.
This correction does not interfere with the antigen-
dependence of results and does not influence the inter-
pretation of data for statistical analysis and representa-
tion of results for diagnostic purposes.
Intracellular staining
PBMC were incubated with brefeldin A (Golgi plug)
(Pharmingen, San Diego, CA, USA) added during the last
3 hours of culture. Cells were then stained with PE conju-
gated mAb anti-CD4 (clone SK3, mouse IgG1) or anti-
CD8 (clone SK1, mouse IgG1) from BD Pharmingen and
were incubated with FITC-conjugated anti-IFN-γ (clone
4S.B3, mouse IgG1) from BD Pharmingen after treatment
with Cytofix-Cytoperm reagent (BD Pharmingen) accord-
ing to the manufacturer's instructions.
Flow cytometry was performed on a FACSCanto flow
cytometer (Becton Dickinson, San Jose, CA) analyzing
Table 1: Demographic and clinical characteristics of enrolled individuals
Active TB
N. 20
LTBI subjects
N. 11
Healthy subjects
N. 12
Total
N. 43
Female (%) 10 (50) 4 (36.4) 7 (58.3) 21 (48.8)
Age, median (years) 35.7 42.0 45.1 40.9
Ethnicity:
West Europe (%) 10 (50) 9 (81.8) 12 (100) 31 (72)
East Europe (%) 4 (20) - - 4 (9.3)
South America (%) 1 (5) 1 (9) - 2 (4.6)
Africa (%) 3 (15) - - 3 (6.9)
Asia (%) 2 (10) 1 (9) - 3 (6.9)
BCG vaccinated (%) 7 (35) 0 (0) 1 (8.3) 8 (18.6)
TST positive (%) 12 (60) 11 (100) 1 (8.3) 24 (55.8)
TB localization:
Pulmonary (%) 17 (85) - - 17 (39.5)
Extra-pulmonary (%) 3 (15) - - 3 (6.9)
Positive by QuantiFERON-TB Gold in tube (%) 15 (75) 11 (100) 0 (0) 26 (60.5)
LTBI: Latent TB infectionBMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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50000 viable cells and data were analyzed with the
BDFACS Diva software.
IL-17 and IL-10 detection
IL-17 and IL-10 were detected by commercial Enzyme
Linked ImmunoSorbent Assay (ELISA) kits for human IL-
17 and IL-10 according to the manufacturer's instructions
(R&D Systems, Minneapolis, MN, USA). Detection limit
of the assays is 15 pg/ml.
Statistical Analysis
Control group included 12 healthy subjects. Comparison
of frequencies of IFN-γ, IFN-γ/IL-2 and IL-2-secreting cells
and ELISA measures among groups were tested using the
Mann-Whitney U test. A p < 0.05 was considered signifi-
cant.
Receiver operating characteristic (ROC) curves were con-
structed plotting sensitivity versus 100-specificity evalu-
ated at several different diagnostic thresholds. The area
under the curve (AUC), the corresponding 95% confi-
dence interval (CI) and p-value were calculated. Optimum
cut-off values, with the combination of the highest sensi-
tivity and specificity, were calculated.
All the analyses were performed using GraphPad Prism
Software 4 (San Diego, CA).
Results
Analysis of M. tuberculosis-specific cytokine-secreting T 
lymphocytes
PBMC from patients and control individuals were stimu-
lated with SEA, PPD, ESAT-6/CFP-10 and BCG or left un-
stimulated for 18 or 72 hours and then analysis of cytokine
secreting cells was performed. As shown in one representa-
tive example reporting the frequency of IFN-γ and IL-2-
secreting cells (Figure 1) and detailed in figure 2A, after 18
hours of culture a noticeable but not statistically significant
difference in the number of cytokine secreting T cells was
detectable between groups in cultures stimulated with M.
tuberculosis antigens or BCG, but not in those stimulated
with SEA or left un-stimulated. Due to the reduced time of
in vitro stimulation, it is reasonable to believe that
responder cells were TEM. The frequency of cytokine secret-
ing T cells increased when analysis was performed after 72
hours of culture (Figure 1 and 2A). The statistical analysis
of the results indicates that this method allows the discrim-
ination of active TB and latent TB infection from control
individuals but not between active TB patients and subjects
with latent TB infection upon M. tuberculosis-specific stimu-
lation. Due to the best performance of the test obtained
after 72 hours, we decided to focus our attention on this
time point for the rest of the study.
Gating the population on CD4+ and CD8+ T cells gave the
opportunity to analyze their contribution to the global
cytokine secretion after M. tuberculosis-specific stimula-
tion. The analysis of cytokine secretion by single T cell
subpopulations mirrored the analysis on the whole T cells
(Figure 2A) and antigen-specific cytokine secreting T lym-
phocytes were present not only in the CD4+ but interest-
ingly also in the CD8+  subpopulation (Figure 2B).
Although both CD4+ and CD8+ cytokine secreting cells
were also detectable using the conventional intracellular
cytokine detection method (data not shown), their fre-
quency was higher using our method.
Analysis of IFN-γ secretion by M. tuberculosis-specific T 
lymphocytes
Figure 3A reports the distribution of IFN-γ secreting T cells
in control subjects and patients with active TB or latent TB
infection upon specific stimulation. Statistic analysis of
the results indicates that this method allows the discrimi-
nation of active TB and latent TB infection from control
individuals with all the stimuli used. However, the test did
not allow the discrimination between active TB patients
and subjects with latent TB infection.
Antigen specific cytokine secretion in PBMC of active TB  patients Figure 1
Antigen specific cytokine secretion in PBMC of active 
TB patients. PBMC from control subjects and active TB 
patients were cultured for 18 and 72 hours after stimulation 
with SEA, PPD, ESAT-6/CFP-10 and BCG or left un-stimu-
lated (none). Cells were then treated as specified in the M&M 
section for analysis of secreted cytokines (IFN-γ and IL-2) 
and evaluated on CD16- gated cells by flow cytometry. Data 
from one representative experiment are reported. Numbers 
indicate the percentages of positive cells in the relative quad-
rants.BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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ROC curves are used in diagnostic accuracy studies to
depict the pattern of sensitivities and specificities
observed when performance of the test is evaluated at sev-
eral different diagnostic thresholds and to ascertain the
optimum cut-off with the best combination of sensitivity
and specificity. In order to analyze the performance of our
test, a ROC curve was constructed with different cut-offs of
percentage of IFN-γ secreting cells upon stimulation with
ESAT-6/CFP-10 choosing M. tuberculosis-infected (active
TB and latent TB infection) and healthy individuals as
comparator groups. The curve was positioned near the
desirable upper left corner of the ROC space indicating a
good performance (p-value < 0.0001) of IFN-γ secreting
cell enumeration after ESAT-6/CFP-10 stimulation with
our test in the discrimination of individuals with TB infec-
tion (Figure 3B).
The optimum cut-off (0.1537%) was chosen to compare
the diagnostic value of IFN-γ secretion analyzed at single
cell level upon stimulation with ESAT-6/CFP-10 with the
Analysis of antigen-specific cytokines secreted by T cells Figure 2
Analysis of antigen-specific cytokines secreted by T cells. A) Frequency of cytokine secreting cells after 18 (left panel) 
or 72 (right panel) hours of culture with the positive control SEA, PPD, ESAT-6/CFP-10 or BCG in PBMC of controls (CTR, 
black bars), patients with active TB (TB Act, white bars) or individuals with latent TB infection (TB Lat, grey bars). Columns 
represent median values ± standard error of the frequency (%) of the total cytokines (IFN-γ, IL-2 and IFN-γ/IL-2) secreting cells 
calculated on CD16- total T cells. Only the statistically significant (p-values < 0.05) differences among the indicated populations 
were reported. * indicates p < 0.05; *** indicates p < 0.005. B) Frequency of cytokine secreting cells among the CD8+ (left 
panel) or the CD4+ (right panel) cells in PBMC of controls (CTR), patients with active TB (TB Act) or individuals with latent TB 
infection (TB Lat) after 72 hours of culture with PPD, ESAT-6/CFP-10 or BCG. Columns represent median values ± standard 
error. Differences among the indicated populations were considered significant when the p-values were < 0.05. * indicates p < 
0.05; ** indicates p < 0.01; *** indicates p < 0.005; n.s. = not significant.BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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standard QuantiFERON (cut-off = 0.35 U.I./ml). Our test
identified 27 out of 31 M. tuberculosis-infected individuals
(87.1%), while QuantiFERON TB Gold in tube identified
26 out 31 M. tuberculosis-infected individuals (83.87%).
Analysis of IL-2 secretion by M. tuberculosis specific T 
lymphocytes
The concomitant detection of IL-2 and IFN-γ on M. tuber-
culosis-specific T cells allowed the identification of three
different populations: cells secreting only IFN-γ or IL-2,
respectively, and cells secreting both cytokines.
In order to evaluate the diagnostic value of IL-2-secreting
cell enumeration, we analyzed the distribution of T cells,
that actively secrete IL-2 irrespective of their IFN-γ secre-
tion, among groups. Interestingly, the percentage of IL-2-
secreting T cells in individuals with latent TB was statisti-
cally higher than in patients with active disease when PPD
(p = 0.008) or BCG (p = 0.015) were used as stimuli (Fig-
ure 4A).
To validate the possibility to discriminate individuals
with latent TB infection from both controls and patients
with active TB using PPD or BCG-induced IL-2 secretion,
we constructed the corresponding ROC curves. IL-2-
secreting cell enumeration after PPD or BCG stimulation
with our test was associated with a good performance in
the discrimination of individuals with latent TB infection
from both active TB patients and control subjects (Figure
4B).
Identification of M. tuberculosis-infected individuals according to IFN-γ secretion Figure 3
Identification of M. tuberculosis-infected individuals according to IFN-γ secretion. A) Distribution of IFN-γ secreting 
T cells in PBMC of controls (CTR), patients with active TB (TB Act) or individuals with latent TB infection (TB Lat) stimulated 
for 72 hours with PPD, ESAT-6/CFP-10 or BCG. Horizontal lines indicate the median. Differences between the indicated pop-
ulations were considered significant when the p-values (indicated by the numbers) were < 0.05. B) ROC curve (on the left) was 
generated plotting sensitivity (%) versus 100%-specificity% to examine the effect of different cut-points of the percentage of 
ESAT-6/CFP-10-specific IFN-γ secreting T cells in TB patients, irrespective of disease stage, versus control subjects. Squares 
indicate the various percentage cut-off values used to calculate the corresponding sensitivity and specificity. Arrow indicates 
the optimum cut-off (0.1537%) with the best combination of sensitivity and specificity. On the right the AUC and the statistical 
significance of the ROC curve and the sensitivity and specificity corresponding to the optimum cut-off are indicated.BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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Analysis of IL-17 and IL-10 secretion following stimulation 
with M. tuberculosis antigens
To test the possible contribution of IL-17 secretion in the
diagnosis of the different forms of TB, we measured the
content of this cytokine in supernatants of 72 hour cul-
tures of stimulated PBMC from 14 active TB patients and
6 healthy controls. The difference in the secretion of IL-17
with or without stimulation with SEA (positive control)
was statistically significant (p < 0.01) but differences in
the secretion of IL-17 between controls and TB patients
were not significant (Figure 5A). Also, no significant dif-
ference was observed between controls and active TB
patients stimulated with PPD and ESAT-6/CFP-10 (Figure
5A). PPD-induced IL-17 secretion was higher than in
healthy controls in three (average of 104 pg/ml) out of 14
patients, but we could not identify any clinical character-
istic of these subjects correlating with the increased IL-17
release.
We also evaluated the frequency of IL-10 producing cells
by flow cytometry and IL-10 concentrations by ELISA
upon stimulation with the same M. tuberculosis antigens
and BCG. IL-10 producing cells were not detected in any
of the subjects examined by flow cytometry (data not
shown) and no secretion of IL-10 was detected in PBMC
cultures from control subjects or active TB patients stimu-
lated with PPD, ESAT-6/CFP-10 or BCG (Figure 5B). IL-10
was only detected in supernatants of PBMC stimulated
with SEA but no correlation with superantigen dependent
IL-10 secretion and TB infection was identified.
Discussion
Tests based on IFN-γ release after PBMC stimulation with
M. tuberculosis specific antigens have been recently intro-
duced. These ELISA or ELISPOT tests contribute to the
study of T cell responses in TB, and represent an important
advance in diagnosis, since they may allow discrimination
of BCG-vaccinated from infected individuals
[10,15,16,18]. However, a series of limitations to these
tests call for a research aimed at ameliorating cytokine
release detection [8,13]. In this line, methods to enumer-
ate cytokine-secreting lymphocytes by flow cytometry
have been proposed [27,28]. The most promising are
based on cytokine detection by intracellular staining,
which is possible only after cell fixation and permeabili-
zation with cytokine release blocking substances. M. tuber-
culosis specific cells have low frequencies in PBMC and
these procedures do not always guarantee the accumula-
tion of an amount of cytokine high enough to be detected
by intracellular antibodies. For this reason some of these
methods use co-stimulatory antibodies to increase the
cytokine secretion capacity of T cells [27].
In the present work we adapted a commercially available
cytokine-secretion method at single living-cell level [22,23]
to study T cell responses in M. tuberculosis infection. The use
of this approach allows the identification and enumeration
of living cells actively secreting the cytokines of interest
upon specific stimulation, and also their characterization
on the basis of membrane expression of selected markers.
Identification of latently M. tuberculosis-infected individuals  according to IL-2 secretion upon stimulation with PPD and  BCG Figure 4
Identification of latently M. tuberculosis-infected indi-
viduals according to IL-2 secretion upon stimulation 
with PPD and BCG. A) Distribution of the frequencies (%) 
of IL-2-secreting T cells in PBMC of patients with active TB 
(TB Act) or individuals with latent TB infection (TB Lat) stim-
ulated for 72 hours with PPD, ESAT-6/CFP-10 or BCG. Hor-
izontal lines indicate the median. Differences among the 
populations were considered significant when the p-values 
(indicated by the numbers) were < 0.05. B) ROC curves (on 
the left) were generated plotting sensitivity (%) versus 100%-
specificity% to examine the effect of different cut-points of 
the percentage of PPD-specific (on the top) or BCG-specific 
(on the bottom) IL-2 secreting T cells in latently infected 
individuals versus both control subjects and active TB 
patients. Squares indicate the various percentage cut-off val-
ues used to calculate the corresponding sensitivity and specif-
icity. Arrows indicate the optimum cut-offs (0.35% and 0.25% 
for PPD and BCG, respectively) with the best combination of 
sensitivity and specificity. On the right the corresponding 
AUC and statistical significances of the ROC curves and the 
sensitivity and specificity corresponding to the optimum cut-
offs are indicated.BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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The frequency of cytokine secreting cells after 72 hours was
higher than after 18 hours and sufficient to discriminate
with high efficiency M. tuberculosis-infected individuals
from controls. Due to the characteristics of the method, the
increased frequency of secreting cells after 72 hours was not
due to an additive effect of cytokines secreted during the
three day culture, but it consisted of an increased number
of cells effectively secreting cytokines. TEM are terminal
cells exerting their functions, such as cytokine secretion,
upon encounter with antigen presenting cells (APC). They
subsequently are programmed to die [19,29]. Thus, the
increased frequency found after a three-day culture is likely
to represent the contribution of CEM cells that, upon stim-
ulation, undergo cell division and cytokine secretion [29].
Probably due to the cumulative analysis of both M. tubercu-
losis specific CEM and TEM populations, the specificity and
the sensitivity of our test reached high levels. The enumera-
tion of the sole IFN-γ secreting cells upon ESAT-6/CFP-10
stimulation was sufficient to discriminate M. tuberculosis-
infected individuals from controls. In fact, the contribution
of IL-10 and IL-12 secreting cells was irrelevant. Some
papers reported levels of IL-10 in TB patients higher than in
healthy controls [30]. IL-10 observed in other publications
might be dependent on IL-10 release by natural regulatory
T cells, that are not stimulated in an antigen specific assay
or by using co-stimulating antibodies to increase the
cytokine secretion [28]. On the other hand, we observed a
trend for IL-2-secreting cells to be detected at frequencies
that are higher in individuals with latent TB infection than
in those with active disease. The difference was statistically
significant when PPD and BCG were used as stimuli, but
not significant upon ESAT-6/CFP-10 stimulation. Since the
number of epitope specific CEM is relatively small, it is not
surprising that responses of increased magnitude are
obtained using antigen mixtures such as PPD or the whole
mycobacterium (BCG), and not with single antigens such
as ESAT-6/CFP-10. These data are likely to reflect the
increased number of IL-2 or IL-2/IFN-γ-secreting CEM and
the reduced number of IFN-γ-secreting TEM in individuals
with latent TB infection in comparison to active TB
patients, due to the absence of M. tuberculosis replication
and, consequently, antigen load [16,21]. However, a larger
study is required to confirm these data and to exclude any
possible role of environmental mycobacteria.
Our data are in agreement with the recent observation by
Millington et al. describing the increase of M. tuberculosis
specific IL-2 and IL-2/IFN-γ-secreting T cells in the follow-
up of active TB treated patients [21]. The emergence of IL-
2 secreting cells in patients after antibiotic treatment
could be considered as the consequence of the expansion
of a new population of cells that can be considered CEM,
caused by the reduced mycobacterial antigen load.
Recently,  M. tuberculosis-specific IL-17 secreting T cells
have been described [31,32] and a role of these T helper
(Th)17 cells in the pathogenesis of TB hypothesized [33].
Since IL-17 secretion has been associated to chronic
inflammations [34,35], we sought to determine its spe-
cific secretion in the attempt to identify a surrogate marker
of active disease. However, ESAT-6/CFP-10 stimulated
PBMC from active TB patients, similarly to control
donors, did not secrete IL-17. Only 3 out of 14 patients
showed a specific IL-17 secretion upon stimulation with
PPD, but these patients showed no clinical signs correlat-
ing with the increased IL-17 secretion. Our data confirm
that PPD-specific Th17 cells are detected in some active TB
patients, but analyses on a larger population would be
required to verify whether circulating PPD-specific Th17
cells play any role in disease pathogenesis.
In our assay we noticed the contribution of CD8+ T cells to
the cytokine secretion upon M. tuberculosis specific stimu-
lation. Although previous papers reported the participa-
Secretion of IL-17 and IL-10 by PBMC stimulated with M.  tuberculosis antigens Figure 5
Secretion of IL-17 and IL-10 by PBMC stimulated 
with M. tuberculosis antigens. PBMC of controls (black 
bars, n = 6) or patients with TB (white bars, n = 14) were 
activated with SEA, PPD or ESAT-6/CFP-10 or left un-stimu-
lated (None). After 72 hours supernatants were collected 
and examined for A) IL-17 and B) IL-10 content by ELISA. 
Detection limit of the assays is 15 pg/ml. Histograms repre-
sent the median value of cytokine secretion after each stimu-
lus expressed in pg/ml.BMC Infectious Diseases 2009, 9:99 http://www.biomedcentral.com/1471-2334/9/99
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tion of CD8+ T cells in cytokine secretion [36-38], we were
surprised to observe a CD8+ T cell response using PPD and
ESAT-6/CFP-10, which are soluble antigens and therefore
processed in late-endosomes [39] for presentation to
CD4+ T cells. It is possible to speculate that ESAT-6 can be
cross-presented [40] by APC after phagocytosis of apop-
totic cells, since recent data indicate the capacity of ESAT-
6 to induce apoptosis [41]. Moreover, ESAT-6 and other
RD1 associated proteins could possibly be directly
involved in the endoplasmic reticulum migration from
the cytoplasm in a lysteriolysin-like mechanism, as sug-
gested by recent observations [42,43]. Beyond the possi-
ble added value for TB diagnosis, the observation of
cytokine secretion by CD8+  T cells corroborates the
hypothesis of their contribution to the anti-M. tuberculosis
immune response [44,45] and encourages further studies
aimed at correlating CD8+ T cell activation with different
clinical stages or prognostic indexes of TB [46].
Conclusion
We have developed a simple and reliable flow cytometric
method to study the antigen specific T cell response in TB.
Our assay presents several advantages as compared to
other previously described methods based on cytokine
release. Moreover, its excellent performance would make
it suitable for diagnostic purposes even in field studies
[47]. In fact, our preliminary data indicate that detection
of IL-2 in IFN-γ positive subjects, after stimulation with M.
tuberculosis antigens, may discriminate individuals with
latent infection from patients affected by active TB. Lastly,
since this method allows the contemporaneous evalua-
tion of at least two cytokines it could represent a reference
method to track IL-2-secreting T cells and to monitor the
efficacy of anti-TB therapy.
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